Zachary Watson, PhDUniversity of Colorado DenverAurora, CO The influence of bone marrow-derived adipocytes on pro-tumor signaling and lipid metabolism in ovarian cancer Dr. Watson is investigating a potential driver of ovarian cancer development to lay the foundation for discovering new early detection and treatment strategies. Ovarian cancer spreads aggressively into abdominal fat deposits, which often […]
Read More
Utthara Nayar, PhDJohns Hopkins UniversityBaltimore, MD Estrogen receptor mutations as a novel biomarker for response to endocrine therapy in ovarian cancer Dr. Nayar is pursuing a fast track to the clinical testing of a new treatment for low-grade serous ovarian cancers (LGSOCs). Some LGSOCs develop mutations in the estrogen receptor (ER) molecule and stop responding […]
Read More
Elizabeth Swisher, MDUniversity of WashingtonSeattle, WA Optimizing genetic testing uptake and outcomes for hereditary ovarian cancer risk As genetic testing for cancer risk becomes increasingly accessible, the goal of eradicating hereditary ovarian cancer through comprehensive genetic testing and effective prevention is tantalizingly close. However, several large studies have revealed that a large minority of people […]
Read More
Holly R. Harris, MPH, ScDFred Hutchinson Cancer CenterSeattle, WA Identification of ovarian cancer risk factors among women with endometriosis Although we know endometriosis increases ovarian cancer risk, we do not know how to identify which individuals with endometriosis will develop ovarian cancer. Dr. Harris will run the first large-scale analysis of women with endometriosis to […]
Read More